feed,title,long_url,short_url
Benzinga,Minerva Neurosciences Shares Sink On Regulatory Setback For Schizophrenia Candidate,https://benzinga.com/general/biotech/22/10/29287659/minerva-neurosciences-shares-sink-on-regulatory-setback-for-schizophrenia-candidate,https://bit.ly/3T9a6y0
Benzinga,Panchaea works with NVIDIA to power 3D internet's future via Cudo Compute,https://benzinga.com/markets/cryptocurrency/22/10/29288066/panchaea-works-with-nvidia-to-power-3d-internets-future-via-cudo-compute,https://bit.ly/3ggdHfb
Benzinga,MacroGenics Shares Jump On Gilead Licensing Pact For Blood Cancer Candidates,https://benzinga.com/general/biotech/22/10/29286223/macrogenics-shares-jump-on-gilead-licensing-pact-for-blood-cancer-candidates,https://bit.ly/3MA1xK8
Benzinga,NGM Bio Plunges As Experimental Drug Fails To Meet Primary Goal In Age-Related Vision Loss Disorder,https://benzinga.com/general/biotech/22/10/29285884/ngm-bio-plunges-as-experimental-drug-fails-to-meet-primary-goal-in-age-related-vision-loss-disord,https://bit.ly/3Tcbdx0
